Latest News and Press Releases
Want to stay updated on the latest news?
-
Ophirex will supply marimastat to Liverpool School of Tropical Medicine's Centre for Snakebite Research & Interventions’ (CSRI) Ph2 TOCSINS clinical trial.
-
Ophirex announces regulatory and business developments as it continues to advance varespladib as the first oral rescue treatment for snakebite.